CClinicalTrials.gg
CompletedNCT07124169Updated Aug 15, 2025

Therapeutic Effects of Kinesiotape in the Management of Gonarthrosis

An interventional study of Kinesiotape + home exercise and Home exercise in Gonarthrosis, sponsored by Fenerbahce University. Completed. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-15.

Sponsored by Fenerbahce University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 years 9 months after the study started (first participant enrolled Nov 2015, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated the effectiveness of kinesiotaping in addition to exercise for patients with knee osteoarthritis (gonarthrosis). Thirty-eight participants aged 45 to 65 were randomly assigned to two groups: one group performed a structured home exercise program three times weekly for 6 weeks, while the other group performed the same program and also received kinesiotaping once weekly. Outcomes included pain, stiffness, balance, and quality of life. Both groups demonstrated significant improvement; however, the kinesiotaping plus exercise group showed greater gains in pain reduction, mobility, and daily activities. These findings suggest that kinesiotaping combined with exercise may provide superior benefits compared with exercise alone in individuals with knee osteoarthritis.

02

Conditions studied

  • Gonarthrosis

Keywords

  • gonarthrosis
  • kinesiotape
  • home exercises
03

In context

Osteoarthritis, Knee

3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.

This study's enrollment of 38 is below the median of 70 across 2,731 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Fenerbahce University is the lead sponsor of 73 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • having a diagnosis of primary gonarthrosis according to ACR classification criteria,
  • being between 45 and 65 years of age,
  • having a radiological diagnosis of gonarthrosis between Kellgren-Lawrence stage 1-3 ,
  • signing the informed consent

Exclusion criteria

Exclusion Criteria:

  • presence of a neurological disorder affecting muscle strength or balance,
  • history of any surgical operation on the knee, hip or spine,
  • physiotherapy or injections for the knee within the previous year,
  • presence of systemic conditions such as diabetes mellitus, vertigo, visual problems,
  • history of severe trauma within the previous year
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Experimental (Kinesiotape+home exercise)

    The taping procedure was repeated once a week, starting from the first week, for a total of 6 sessions. Mechanical correction technique and Ligament/Tendon correction technique, as kinesiotape application, were performed. ). A 6-week home exercise program was given to both the taping and control groups, three sessions per week. An individualized home exercise program was planned, considering EULAR and ACR recommendations. Each participant was given a structured home exercise program for approximately 30 minutes per day, at least 3 days a week. The program included moderate-intensity aerobic exercises (e.g., walking) and muscle-strengthening exercises targeting the quadriceps and hamstring muscles, along with flexibility and balance exercises. ).

    Other: Kinesiotape + home exercise

  • Active comparator
    control (home exercise )

    A 6-week home exercise program was given to both the taping and control groups, three sessions per week. An individualized home exercise program was planned, considering EULAR and ACR recommendations. Each participant was given a structured home exercise program for approximately 30 minutes per day, at least 3 days a week. The program included moderate-intensity aerobic exercises (e.g., walking) and muscle-strengthening exercises targeting the quadriceps and hamstring muscles, along with flexibility and balance exercises.

    Other: Home exercise

Interventions

  • OtherKinesiotape + home exercise

    Kinesiotaping will be applied to the knee once weekly for 6 weeks. In addition, participants will perform a structured home exercise program three times per week, including strengthening, stretching, and balance exercises.

  • OtherHome exercise

    In addition, participants will perform a structured home exercise program three times per week, including strengthening, stretching, and balance exercises.

06

What researchers measure

Primary outcomes

  1. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    WOMAC consists of 24 questions in total (pain 5, joint stiffness 2, functional status 17). Each question was scored on a scale of 1-5. A high score indicates poor health, while a low score indicates good health.

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. Visual Analogue Scale (VAS)

    VAS, which ranges from 0 to 10, is used to assess pain levels. A score of 0 represents no pain, while 10 indicates the most severe, unbearable pain. Participants were instructed to indicate their perceived pain level by marking a 10 cm straight line, and the corresponding value was recorded in centimeters.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Berg Balance Scale (BBS)

    BBS is a test consisting of 14 items used to evaluate the functional balance of individuals. The application time is approximately 15-20 minutes, and the following materials are needed: a ruler, a stopwatch, a chair, a step, and an area suitable for 360-degree rotation. Each item is evaluated on a scale of 0-4 points based on the individual's ability to perform the given task independently and correctly. The total score is 56. A score between 0-20 indicates severe balance impairment, between 21-40 indicates acceptable balance, and between 41-56 indicates good balance.

    Time frame: From enrollment to he end of treatment at 6 weeks.

  3. Short Form (SF-36)

    The SF-36 questionnaire was developed to assess quality of life. A total of 8 sub-parameters, including pain, social functioning, energy/vitality, emotional role difficulties, physical role difficulties, physical functioning, general health perception, and mental health, are examined

    Time frame: From enrollment to the end of treatment at 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

  • Protocol and statistical analysis plan · Nov 25, 2015

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Individual participant data will not be shared due to concerns regarding patient confidentiality and data privacy

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07124169
Lead sponsor
Fenerbahce University
Responsible party
Burcu AKKURT (assistant professor, Fenerbahce University) — Principal investigator
First posted
Aug 15, 2025
Start date
Nov 2015
Primary completion
Jan 2016
Completion
Jun 2016
Last update
Aug 15, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion